Maintaining Continuity of Clinical Research in the Era of COVID-19
Thought Leadership Lightning Round
Bio Innovation 2020 | 05 October, 2020
Our President of Clinical Research, Kathy Dimeo, took to the podium to share insights gleaned from our recent patient-centric COVID-19 clinical trials as well as looking at the strategic approaches that we have taken to mitigate and manage non COVID-19 clinical trials throughout the pandemic. The session explores:
- The impact of COVID-19 on Clinical Research
- Clinical research responses to the pandemic
- A Case Study – supporting accelerated execution of a clinical trial for an anti-viral therapeutic treatment for COVID-19
- With the CRO industry at an inflection point, has COVID-19 changed clinical trials forever?
To download and listen to her session Maintaining Continuity of Clinical Research in the Era of COVID-19 please complete the form.